Deregulation of retinaldehyde dehydrogenase 2 leads to defective angiogenic function of endothelial colony-forming cells in pediatric moyamoya disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 7, 2015, Pages 1670-1677

  Lee, Ji Yeoun ^a   Moon, Youn Joo ^a   Lee, Hae Ock ^c,e   Park, Ae Kyung ^d   Choi, Seung Ah ^a   Wang, Kyu Chang ^a   Han, Jung Woo ^a   Joung, Je Gun ^c   Kang, Hyun Seung ^b   Kim, Jeong Eun ^b   Phi, Ji Hoon ^a   Park, Woong Yang ^c,e   Kim, Seung Ki ^a  

^a Seoul National University Children's Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

^d Sunchon National University   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Arteries; Moyamoya disease; RALDH2 protein

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBROBLAST GROWTH FACTOR 2; GELATINASE B; HISTONE H3; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RETINAL DEHYDROGENASE; RETINAL DEHYDROGENASE 2; RETINOIC ACID; SCATTER FACTOR; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; ALDH1A2 PROTEIN, HUMAN;

ARTICLE; CAPILLARY; CELL ISOLATION; CHILDHOOD DISEASE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR PATHOLOGY; MOYAMOYA DISEASE; PRIORITY JOURNAL; PROMOTER REGION; ENZYMOLOGY; GENETIC EPIGENESIS; GENETICS; METABOLISM;

ENDOTHELIAL CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; HUMANS; MOYAMOYA DISEASE; RETINAL DEHYDROGENASE; RNA, MESSENGER; TRETINOIN;

EID: 84933056575     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.305363     Document Type: Article

References (30)

1. Suzuki J, Kodama N., Moyamoya disease-a review. Stroke 1983 14 104 109
2. Suzuki J, Takaku A., Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969 20 288 299
3. Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, Cho BK, Kim SK., Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 2010 81 673 678. doi: 10.1136/jnnp.2009.191817
4. Kassner A, Zhu XP, Li KL, Jackson A., Neoangiogenesis in association with moyamoya syndrome shown by estimation of relative recirculation based on dynamic contrast-enhanced MR images. AJNR Am J Neuroradiol 2003 24 810 818
5. Im SH, Oh CW, Kwon OK, Kim JE, Han DH., Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management. J Neurosurg 2005 102 1013 1017. doi: 10.3171/jns.2005.102.6.1013
6. Yamada H, Deguchi K, Tanigawara T, Takenaka K, Nishimura Y, Shinoda J, Hattori T, Andoh T, Sakai N., The relationship between moyamoya disease and bacterial infection. Clin Neurol Neurosurg 1997 99 suppl 2 S221 S224
7. Kamada F, Aoki Y, Narisawa A, A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet 2011 56 34 40. doi: 10.1038/jhg.2010.132
8. Kim SK, Yoo JI, Cho BK, Hong SJ, Kim YK, Moon JA, Kim JH, Chung YN, Wang KC., Elevation of CRABP-I in the cerebrospinal fluid of patients with Moyamoya disease. Stroke 2003 34 2835 2841. doi: 10.1161/01.STR.0000100159.43123.D7
9. Rhee EJ, Nallamshetty S, Plutzky J., Retinoid metabolism and its effects on the vasculature. Biochim Biophys Acta 2012 1821 230 240. doi: 10.1016/j.bbalip.2011.07.001
10. Kim JH, Jung JH, Phi JH, Kang HS, Kim JE, Chae JH, Kim SJ, Kim YH, Kim YY, Cho BK, Wang KC, Kim SK., Decreased level and defective function of circulating endothelial progenitor cells in children with moyamoya disease. J Neurosci Res 2010 88 510 518. doi: 10.1002/jnr.22228
11. Rafat N, Beck GCh, Peña-Tapia PG, Schmiedek P, Vajkoczy P., Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease. Stroke 2009 40 432 438. doi: 10.1161/STROKEAHA.108.529420
12. Yoshihara T, Taguchi A, Matsuyama T, Shimizu Y, Kikuchi-Taura A, Soma T, Stern DM, Yoshikawa H, Kasahara Y, Moriwaki H, Nagatsuka K, Naritomi H., Increase in circulating CD34-positive cells in patients with angiographic evidence of moyamoya-like vessels. J Cereb Blood Flow Metab 2008 28 1086 1089. doi: 10.1038/jcbfm.2008.1
13. Jung KH, Chu K, Lee ST, Park HK, Kim DH, Kim JH, Bahn JJ, Song EC, Kim M, Lee SK, Roh JK., Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease. J Cereb Blood Flow Metab 2008 28 1795 1803. doi: 10.1038/jcbfm.2008.67
14. Houkin K, Ito M, Sugiyama T, Shichinohe H, Nakayama N, Kazumata K, Kuroda S., Review of past research and current concepts on the etiology of moyamoya disease. Neurol Med Chir (Tokyo) 2012 52 267 277
15. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K, Roh TY, Peng W, Zhang MQ, Zhao K., Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008 40 897 903. doi: 10.1038/ng.154
16. Karlić R, Chung HR, Lasserre J, Vlahovicek K, Vingron M., Histone modification levels are predictive for gene expression. Proc Natl Acad Sci USA 2010 107 2926 2931. doi: 10.1073/pnas.0909344107
17. Miano JM, Berk BC., Retinoids: versatile biological response modifiers of vascular smooth muscle phenotype. Circ Res 2000 87 355 362
18. Lai L, Bohnsack BL, Niederreither K, Hirschi KK., Retinoic acid regulates endothelial cell proliferation during vasculogenesis. Development 2003 130 6465 6474. doi: 10.1242/dev.00887
19. Niederreither K, Vermot J, Messaddeq N, Schuhbaur B, Chambon P, Dollé P., Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse. Development 2001 128 1019 1031
20. Gidlöf AC, Ocaya P, Krivospitskaya O, Sirsjö A., Vitamin A: a drug for prevention of restenosis/reocclusion after percutaneous coronary intervention? Clin Sci (Lond) 2008 114 19 25. doi: 10.1042/CS20070090
21. Streb JW, Miano JM., Retinoids: pleiotropic agents of therapy for vascular diseases? Curr Drug Targets Cardiovasc Haematol Disord 2003 3 31 57
22. Johst U, Betsch A, Wiskirchen J, Schöber W, Vonthein R, Rinkert N, Kehlbach R, Claussen CD, Duda SH., All-trans and 9-cis retinoid acids inhibit proliferation, migration, and synthesis of extracellular matrix of human vascular smooth muscle cells by inducing differentiation in vitro. J Cardiovasc Pharmacol 2003 41 526 535
23. Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on Atherothrombosis Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009 54 2129 2138. doi: 10.1016/j.jacc.2009.09.009
24. Saito A, Sugawara A, Uruno A, Kudo M, Kagechika H, Sato Y, Owada Y, Kondo H, Sato M, Kurabayashi M, Imaizumi M, Tsuchiya S, Ito S., All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling. Endocrinology 2007 148 1412 1423. doi: 10.1210/en.2006-0900
25. Niederreither K, Subbarayan V, Dollé P, Chambon P., Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nat Genet 1999 21 444 448. doi: 10.1038/7788
26. Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T., Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol 2009 72 476 480. doi: 10.1016/j.surneu.2008.10.009
27. Johnson C, Galis ZS., Matrix metalloproteinase-2 and-9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol 2004 24 54 60. doi: 10.1161/01.ATV.0000100402.69997.C3
28. Dutta A, Sen T, Chatterjee A., All-trans retinoic acid (ATRA) downregulates MMP-9 by modulating its regulatory molecules. Cell Adh Migr 2010 4 409 418
29. Klein G, Vellenga E, Fraaije MW, Kamps WA, de Bont ES., The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol 2004 50 87 100. doi: 10.1016/j.critrevonc.2003.09.001
30. Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B., Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients. Acta Neurochir (Wien) 2010 152 2153 2160. doi: 10.1007/s00701-010-0711-9